Campylobacter upsaliensis

From WikiMD's WELLNESSPEDIA

A species of bacteria associated with gastrointestinal infections


Campylobacter upsaliensis is a species of bacteria within the genus Campylobacter. It is a Gram-negative bacterium that is known to cause gastrointestinal infections in humans. This species is often associated with domestic animals, particularly dogs and cats, which can act as reservoirs for the bacterium.

Morphology[edit]

Campylobacter upsaliensis is a spiral-shaped bacterium, characteristic of the Campylobacter genus. It is microaerophilic, requiring reduced levels of oxygen for growth. The bacterium is motile, possessing a single polar flagellum that allows it to move in a corkscrew motion.

Pathogenicity[edit]

Campylobacter upsaliensis is an emerging pathogen in human gastroenteritis. It is less commonly identified than Campylobacter jejuni and Campylobacter coli, but it can cause similar symptoms, including diarrhea, abdominal pain, and fever. The infection is typically self-limiting, but in some cases, it may require antibiotic treatment.

Transmission[edit]

The primary mode of transmission of Campylobacter upsaliensis to humans is through contact with infected animals, particularly pets such as dogs and cats. The bacterium can also be transmitted through the consumption of contaminated food or water.

Diagnosis[edit]

Diagnosis of Campylobacter upsaliensis infection is typically performed through stool cultures. However, this species is more difficult to culture than other Campylobacter species, which can lead to underdiagnosis. Molecular methods such as PCR are increasingly used for detection.

Treatment[edit]

Most infections with Campylobacter upsaliensis are self-limiting and do not require treatment. In severe cases, antibiotics such as azithromycin or ciprofloxacin may be prescribed. It is important to maintain hydration during the course of the illness.

Prevention[edit]

Preventive measures include practicing good hygiene when handling pets, ensuring proper food safety practices, and avoiding consumption of undercooked or contaminated food.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.